Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 31;10(1):63.
doi: 10.1186/s13756-021-00931-w.

Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture

Affiliations
Review

Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture

Katia Iskandar et al. Antimicrob Resist Infect Control. .

Abstract

Data on comprehensive population-based surveillance of antimicrobial resistance is lacking. In low- and middle-income countries, the challenges are high due to weak laboratory capacity, poor health systems governance, lack of health information systems, and limited resources. Developing countries struggle with political and social dilemma, and bear a high health and economic burden of communicable diseases. Available data are fragmented and lack representativeness which limits their use to advice health policy makers and orientate the efficient allocation of funding and financial resources on programs to mitigate resistance. Low-quality data means soaring rates of antimicrobial resistance and the inability to track and map the spread of resistance, detect early outbreaks, and set national health policy to tackle resistance. Here, we review the barriers and limitations of conducting effective antimicrobial resistance surveillance, and we highlight multiple incremental approaches that may offer opportunities to strengthen population-based surveillance if tailored to the context of each country.

Keywords: Antimicrobial resistance; Low- and Middle-Income countries; Surveillance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. O’Neill J. Review on antimicrobial resistance: antimicrobial resistance: tackling a crisis for the health and wealth of nations. London: Wellcome Trust; 2014.
    1. Adeyi O, Baris E, Jonas O, Irwin A, Berthe F, Le Gall F, et al. Drug-resistant infections: a threat to our economic future. Washington, DC: World Bank Group; 2017.
    1. World Health Organization . Global action plan on antimicrobial resistance. Geneva: WHO; 2015. p. 2017. - PubMed
    1. World Health Organization . Antimicrobial resistance global report on surveillance: 2014 summary. World Health Organization; 2014.
    1. de Kraker ME, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med. 2016;13(11):e1002184. doi: 10.1371/journal.pmed.1002184. - DOI - PMC - PubMed

Substances